Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: ZYMERON CORPORATION
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2023-09-15 to 2026-01-14
Current total value of award: $2999998.63
Description: DHA SBIR DIRECT TO PH II MEDICAL R&D CONTRACT AWARDED FROM PROPOSAL NO.-H2D-0119 FOR "DEVELOPMENT FOR SHOCKDEFENDER AGAINST HEMORRHAGIC SHOCK"